FOLH1 and prostate cancer: For instance, the synthetic ligand DUPA (2-[3-(1,3-dicarboxypropyl) ureido] pentanedioic acid) was identified based on its specificity toward prostate-specific membrane antigen (PSMA), a receptor frequently up-regulated in prostate cancer [61].